Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.32 |
| ▸ | F2R | P25116 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15762046 | 0.79 | MAOA (0.37) | ALDH1A1CYP3A4 | |
| SCHEMBL22330531 | 0.78 | GABRA1 (0.32) | GABRA1GABRB2CLCN2F2RCYP3A4 | |
| SCHEMBL17149441 | 0.71 | SMN1; SMN2 (0.42) | ALDH1A1MAPT | |
| SCHEMBL14385795 | 0.71 | MAPT (0.32) | CLCN2ALDH1A1GAAMAPT | |
| SCHEMBL21670064 | 0.69 | GABRA1 (0.35) | GABRA1GABRB2CLCN2F2RALDH1A1 | |
| SCHEMBL27308001 | 0.69 | — | — | |
| SCHEMBL13818687 | 0.68 | CLCN2 (0.34) | GABRA1GABRB2CLCN2F2RALDH1A1 | |
| SCHEMBL6546236 | 0.67 | GABRA1 (0.48) | GABRA1GABRB2CLCN2F2RALDH1A1 | |
| SCHEMBL536538 | 0.67 | GABRA1 (0.40) | GABRA1GABRB2CLCN2F2RALDH1A1 | |
| SCHEMBL24288159 | 0.67 | GABRA1 (0.33) | GABRA1GABRB2CLCN2F2RGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2070909-A1 | Non-steroidal progesterone receptor modulators | Bayer Schering Pharma AG (DE) | 2009-06-17 | — | — | EP | disclosed |